P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY

Gelijkaardige items

• P522: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY
  door: G. Cristiano, et al.
  Gepubliceerd in: (2022-06-01)
• <i>TP53</i> Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
  door: Federico Zingarelli, et al.
  Gepubliceerd in: (2022-11-01)
• PB1865: NPM1-MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS
  door: Chiara Sartor, et al.
  Gepubliceerd in: (2023-08-01)
• P342: BASELINE GENE EXPRESSION ANALYSIS OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH INOTUZUMAB OZOGAMICIN
  door: C. Sartor, et al.
  Gepubliceerd in: (2022-06-01)
• Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia
  door: Samantha Bruno, et al.
  Gepubliceerd in: (2021-09-01)